| 000 | 01478 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513165552.0 | ||
| 264 | 0 | _c19990507 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a1064-1297 | ||
| 024 | 7 |
_a10.1037//1064-1297.7.1.72 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCaskey, N H | |
| 245 | 0 | 0 |
_aThe effects of dopaminergic D2 stimulation and blockade on smoking behavior. _h[electronic resource] |
| 260 |
_bExperimental and clinical psychopharmacology _cFeb 1999 |
||
| 300 |
_a72-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBromocriptine _xpharmacology |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
| 650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaloperidol _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
| 650 | 0 | 4 |
_aSmoking _xpsychology |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 700 | 1 | _aJarvik, M E | |
| 700 | 1 | _aWirshing, W C | |
| 773 | 0 |
_tExperimental and clinical psychopharmacology _gvol. 7 _gno. 1 _gp. 72-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1037//1064-1297.7.1.72 _zAvailable from publisher's website |
| 999 |
_c9997583 _d9997583 |
||